Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and... see more

TSX:WELL - Post Discussion

View:
Post by thinkyourmoney on May 14, 2021 1:45pm

TDOC vs WELL

I just did a little comparison of Well vs TDOC.  I know Tech and Telehealth were "consolidating" lately so I figured I best just crunch a couple of numbers and the closest to WELL is TDOC.

TDOC is half the price that it was when it peaked.  Earnings per share are -$6.27 per share. 

WELL is 70% of its peak price right now.   Net income was -$.04 per share basic and diluted.

TDOC just bought Luvongo which is comparable to WELL buying CRH (or vice versa).  However, in the first quarter TDOC took some big hits and declared substantial losses with paying Livongo stock awards.  

I did not see any such thing on the Q1 report for WELL but then they did not take over CRH until April 22.  What we did get was this update:

CRH is on track to meet and exceed its business plan goal of generating over US$150 million in revenues, US$60 million in EBITDA and US$40 million in free cashflow before leverage and tax costs in 2021.  As a result, WELL’s combined pro forma revenue is now approaching C$300 million with over C$80 million in EBITDA(2) on a run-rate basis


The one thing that is missing for me right now is that CRH as far as I know did not declare a first quarter earnings report.  I gather they would not have to report as they are no longer a listed company.  We will have to wait for a press release from WELL that clarifies that the transition of CRH to WELL was accomplished with a much more positive result that the deal that was made between TDOC and Livongo.

I am under the impression the WELL is moving to positive earnings this year and as early as next quarter.  

Could this be why everyone is holding their breath before the next big bump up???  If we don't hear something before then we will know for sure in August when Q2 earnings are released.
Comment by Duediligence33 on May 14, 2021 2:29pm
Good point and to that issue there were comments by Hammed to an analyst that WELL spent over $ 200,000 to consultants for a deep dive into the financials of CRH and if there was anything of substantial material impact it have to legally be disclosed. Their options and shares based compensation was factored into the takeover price. Next financials will cause a short squeeze to over $ 8 or $ 9 plus ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities